The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature

AASLD, 2014 Abou-Saleh, 2013, Hepatitis C testing in drug users using the dried blood spot test and the uptake of an innovative self-administered DBS test, Addictive Disorders and their Treatment, 12, 40, 10.1097/ADT.0b013e318253c465 Arora, 2013, Rapid point-of-care testing for detection of HIV and clinical monitoring, ISRN AIDS, 2013, 287269, 10.1155/2013/287269 Barrera, 1995, Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA, Vox Sanguinis, 68, 15, 10.1111/j.1423-0410.1995.tb02538.x Bennett, 2012, Detection of hepatitis C virus RNA in dried blood spots, Journal of Clinical Virology, 54, 106, 10.1016/j.jcv.2012.02.004 Centers for Disease and Prevention, 2013, Testing for HCV infection: An update of guidance for clinicians and laboratorians, Morbidity and Mortality Weekly Report, 62, 362 Chung, 2014, Curing chronic hepatitis C – The arc of a medical triumph, New England Journal of Medicine, 370, 1576, 10.1056/NEJMp1400986 Craine, 2009, Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service, Journal of Viral Hepatitis, 16, 219, 10.1111/j.1365-2893.2008.01061.x Craine, 2014, A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons, European Journal of Public Health De Francesco, 2005, Challenges and successes in developing new therapies for hepatitis C, Nature, 436, 953, 10.1038/nature04080 Denniston, 2014, Chronic hepatitis C virus infection in the United States National Health and Nutrition Examination Survey 2003 to 2010, Annals of Internal Medicine, 160, 293 Dokubo, 2014, Comparison of hepatitis C virus RNA and antibody detection in dried blood spots and plasma specimens, Journal of Clinical Virology, 59, 223, 10.1016/j.jcv.2014.01.014 Donato, 2002, Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women, American Journal of Epidemiology, 155, 323, 10.1093/aje/155.4.323 Drobnik, 2011, Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations, American Journal of Public Health, 101, 2151, 10.2105/AJPH.2011.300251 Goldberg, 2008, Hepatitis C action plan for Scotland: Phase II (May 2008–March 2011), Euro Surveillance, 13 Gretch, 1997, Diagnostic tests for hepatitis C, Hepatology, 26, 43S, 10.1002/hep.510260708 Hayes, 2014, Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs, BMC Public Health, 14, 645, 10.1186/1471-2458-14-645 Hickman, 2008, Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: A cluster randomized controlled trial, Journal of Viral Hepatitis, 15, 250, 10.1111/j.1365-2893.2007.00937.x Jewett, 2013, Successful integration of hepatitis C virus point-of-care tests into the Denver Metro Health Clinic, AIDS Research and Treatment, 2013, 528904 Jewett, 2012, Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA, Journal of Clinical Virology, 54, 213, 10.1016/j.jcv.2012.04.003 Judd, 2003, Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots, Journal of Medical Virology, 71, 49 Martin, 2013, Combination interventions to prevent HCV transmission among people who inject drugs: Modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy, Clinical Infectious Diseases, 57, S39, 10.1093/cid/cit296 Martin, 2013, Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons, BMJ Open, 3, 10.1136/bmjopen-2013-003153 Martin, 2011, Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility, Journal of Hepatology, 54, 1137, 10.1016/j.jhep.2010.08.029 Martin, 2013, Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals, Hepatology, 58, 1598, 10.1002/hep.26431 Mason, 2007, Improving access to HCV treatment: External jugular venepuncture can overcome problems with difficult venous access, International Journal of Drug Policy, 18, 433, 10.1016/j.drugpo.2007.01.008 McLeod, 2014, Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing, Journal of Epidemiology and Community Health, 10.1136/jech-2014-204451 Micallef, 2006, Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies, Journal of Viral Hepatitis, 13, 34, 10.1111/j.1365-2893.2005.00651.x Morrill, 2005, Barriers to the treatment of hepatitis C. Patient, provider, and system factors, Journal of General Internal Medicine, 20, 754, 10.1111/j.1525-1497.2005.0161.x Palmateer, 2014, Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions, PLoS One, 9, e104515, 10.1371/journal.pone.0104515 Shepard, 2005, Global epidemiology of hepatitis C virus infection, Lancet Infectious Diseases, 5, 558 Shivkumar, 2012, Accuracy of rapid and point-of-care screening tests for hepatitis C: A systematic review and meta-analysis, Annals of Internal Medicine, 157, 558 SIGN., 2011 Smith, 2012, Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965, Morbidity and Mortality Weekly Report, 61, 1 Tait, 2013, Dry blood spot testing for hepatitis C in people who injected drugs: Reaching the populations other tests cannot reach, Journal of Hepatology, 58, S204, 10.1016/S0168-8278(13)60500-0 White, 2014, Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study, Medical Journal of Australia, 201, 326, 10.5694/mja13.00153 Wiese, 2000, Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study, Hepatology, 32, 91, 10.1053/jhep.2000.8169